DISCLOSEDT+30
ICICI Prudential MNC Fund
Tatva Chintan Pharma Chem Limited · NSE
67,089 sh · ₹12.00 Cr
Filed 31 Jul 2026AMFI portfolioview source
Nippon India ELSS Tax Saver Fund
0.6% of their portfolio
₹92.40 Cr
5,16,700 sh
ICICI Prudential MNC Fund
0.7% of their portfolio
₹12.00 Cr
67,089 sh
ICICI Prudential Commodities Fund
0.2% of their portfolio
₹10.15 Cr
56,748 sh
Mukul Agrawal
Investor
—
5,00,000 sh
FII holding ~flat QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
ICICI Prudential MNC Fund
Tatva Chintan Pharma Chem Limited · NSE
67,089 sh · ₹12.00 Cr
ICICI Prudential Commodities Fund
Tatva Chintan Pharma Chem Limited · NSE
56,748 sh · ₹10.15 Cr
Nippon India ELSS Tax Saver Fund
Tatva Chintan Pharma Chem Limited · NSE
5,16,700 sh · ₹92.40 Cr
Mukul Agrawal
Tatva Chintan Pharma Chem Limited · NSE
5,00,000 sh
Nippon India ELSS Tax Saver Fund
Tatva Chintan Pharma Chem Limited · NSE
5,16,700 sh · ₹61.71 Cr
ICICI Prudential MNC Fund
Tatva Chintan Pharma Chem Limited · NSE
67,089 sh · ₹8.01 Cr
ICICI Prudential Commodities Fund
Tatva Chintan Pharma Chem Limited · NSE
56,748 sh · ₹6.78 Cr
ICICI Prudential Commodities Fund
Tatva Chintan Pharma Chem Limited · NSE
56,748 sh · ₹6.43 Cr
ICICI Prudential MNC Fund
Tatva Chintan Pharma Chem Limited · NSE
67,089 sh · ₹7.60 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
15 announcements on record for this company.
Promoter holding by quarter: Jun 2025 72.0%, Sep 2025 72.0%, Dec 2025 72.0%, Mar 2026 72.0%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.4pp
FII holding by quarter: Jun 2025 3.3%, Sep 2025 3.4%, Dec 2025 4.2%, Mar 2026 3.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— −0.3pp
DII holding by quarter: Jun 2025 5.1%, Sep 2025 3.9%, Dec 2025 3.3%, Mar 2026 3.0%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— −0.4pp
MF holding by quarter: Jun 2025 5.1%, Sep 2025 3.8%, Dec 2025 3.3%, Mar 2026 2.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Nippon India ELSS Tax Saver Fund
Tatva Chintan Pharma Chem Limited · NSE
5,16,700 sh · ₹58.55 Cr
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 72.0%, Sep 2025 72.0%, Dec 2025 72.0%, Mar 2026 72.0%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.4pp
FII holding by quarter: Jun 2025 3.3%, Sep 2025 3.4%, Dec 2025 4.2%, Mar 2026 3.8%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— −0.3pp
DII holding by quarter: Jun 2025 5.1%, Sep 2025 3.9%, Dec 2025 3.3%, Mar 2026 3.0%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— −0.4pp
MF holding by quarter: Jun 2025 5.1%, Sep 2025 3.8%, Dec 2025 3.3%, Mar 2026 2.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
15 announcements on record for this company.